Agoraphobia
Fear of places and situations that might cause panic, helplessness, or embarrassment.
Agoraphobia is an anxiety disorder that often develops after one or more panic attacks.
Symptoms include fear and avoidance of places and situations that might cause feelings of panic, entrapment, helplessness, or embarrassment.
Treatments include talk therapy and medication.
Cluster Number: F-1
Wiki Number: W003
Diagnosis: Agoraphobia
US Patients: 1.7% Adults
World Patients:
Sex Ratio: M-2W
Age Onset: 20+
Brain Area: Extra epinephrine – poor balance
Symptoms: environment unsafe-no escape
Progression: Open spaces or outside home; may lead to 10-30 minute panic attack or PTSD
Causes:
Medications: antidepressants; anti-anxiety
Therapies: relaxation, systematic desensitization, expanding exposuresCBT-50%
Youtube Video: What is Agoraphobia?
Amazon or Library Book:
The Agoraphobia Workbook
Click on the book to link or buy from Amazon.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.06.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Development and validation of the Symptomatic Transdiagnostic Test (S2T)by A Vancappel on January 14, 2023
CONCLUSION: The S2T is a relevant tool for clinicians and researchers to assess the psychopathological profile. The main psychopathological symptoms are negatively related to the psychological skills.
- Psychiatric disorders, personality and neuropsychological alterations in Erdheim-Chester diseaseby Charlotte Soumet-Leman on January 11, 2023
Although neurological manifestations and changes in brain volumes have been described in Erdheim-Chester disease (ECD), it remains unknown whether ECD may be associated with psychiatric symptoms and cognitive dysfunctions. We assessed the presence of psychiatric disorders, changes in temperaments and characters, and neuropsychological performances in 32 ECD patients (mean age = 59) younger than 70, not treated with interferon alpha during the last 6 months, and without other serious illnesses....
- Measuring social phobia symptoms in a community sample of adolescents: An examination of the psychometric properties of the SPAI-23by Markos Apostolakis on January 9, 2023
A number of studies to date examine dimensions of social phobia and anxiety in adolescents. A variety of tools has been developed, along with their abbreviated versions, that are used to assess Social Anxiety (SA) but little research has been devoted to the types of fears they each assess. Due to differences in the content of the multitude of instruments, different aspects of SA are addressed and this leads to confusion when the relationship between SA and other constructs is being investigated....
- The structure of mood and anxiety disorder symptoms in the perinatal periodby Michelle L Miller on January 7, 2023
CONCLUSIONS: A three-factor model consisting of Distress, Fear and Bipolar latent factors was the best-fitting model in pregnancy and the postpartum period and showed stability across time. The structure of internalizing symptoms has important implications for future perinatal research and can be utilized to guide treatment by highlighting which psychiatric symptoms may be most similar during the perinatal period.